Automated system for dispensing methadone at home
COPA, an Automated Medication Dispensing and Remote Management System for at Home Methadone Dispensing - Administrative Supplement
['FUNDING_SBIR_2'] · BERKSHIRE BIOMEDICAL CORPORATION · NIH-10876799
This study is testing a new home medication dispenser called COPA that helps make sure patients get their methadone and other oral medications safely and easily, using fingerprint and dental recognition to confirm their identity.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BERKSHIRE BIOMEDICAL CORPORATION (nih funded) |
| Locations | 1 site (DALLAS, UNITED STATES) |
| Trial ID | NIH-10876799 on ClinicalTrials.gov |
What this research studies
This research focuses on developing an automated medication dispensing system called COPA, designed to deliver methadone and other oral medications to patients at home. The system uses biometric confirmation, including fingerprint and dental recognition, to ensure that the right patient receives their medication. By improving the safety and accessibility of methadone maintenance treatment, this project aims to enhance patient adherence and reduce the risks associated with opioid use. The research also involves extensive testing to meet FDA safety requirements.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing methadone maintenance treatment for opioid use disorder.
Not a fit: Patients who are not currently receiving methadone treatment or those who do not have access to the necessary biometric identification may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a safer and more reliable way for patients to receive methadone treatment at home, potentially improving their health outcomes and quality of life.
How similar studies have performed: While the approach of using automated dispensing systems is gaining traction, this specific application for methadone treatment is relatively novel and has not been extensively tested in similar contexts.
Where this research is happening
DALLAS, UNITED STATES
- BERKSHIRE BIOMEDICAL CORPORATION — DALLAS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TIMBERLAKE, JOHN — BERKSHIRE BIOMEDICAL CORPORATION
- Study coordinator: TIMBERLAKE, JOHN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Disinfection